Great work! - given the Type 1/2 patients you mentioned in part 2, seems like going upstream to value based CKD management also enables improved management of the patient funnel for DaVita/Fresenius, as well as potential to improve their overall health before they potentially fall into a value based ESRD bundle - could help reduce total cost of care.
Great work! - given the Type 1/2 patients you mentioned in part 2, seems like going upstream to value based CKD management also enables improved management of the patient funnel for DaVita/Fresenius, as well as potential to improve their overall health before they potentially fall into a value based ESRD bundle - could help reduce total cost of care.